IDEAS is tackling one of pharmaceutical development’s most persistent challenges: poor drug solubility, which affects an estimated 70–90% of new drug candidates. The Horizon Europe-funded Doctoral Network brings together 16 partners across 10 countries to develop next-generation amorphous drug formulations, predictive models and AI-powered design tools, while training 15 doctoral candidates at the interface of academia and industry. Discover how IDEAS aims to reshape the future of drug formulation.